Mount Yale Investment Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,342	Closed	-$136K	–	557
2018 Q3	$136K	Sell	1,342 -67	-5%	-$6.79K	0.02%	351
2018 Q2	$182K	Buy	1,409 +264	+23%	+$34.1K	0.03%	312
2018 Q1	$118K	Buy	+1,145	New	+$118K	0.03%	400